Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection. (Q46675145)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2005

Language	Label	Description	Also known as
English	Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.	scientific article published in September 2005

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Thierry Poynard

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Vlad Ratziu

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Françoise Degos

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Francoise Imbert-Bismut

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Paul Deny

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Paul Landais

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Abdelkader El Hasnaoui

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Alain Slama

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Vincent Thibault

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Parviz Parvaz

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Mona Munteanu

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Christian Trepo

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

100

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1970-1980

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16128941%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Viral hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Appropriateness of liver biopsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Role of liver biopsy in management of chronic hepatitis C: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Histological outcome during long-term lamivudine therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Histological improvements after a three-year lamivudine therapy in patients with chronic hepatitis B in whom YMDD mutants did not or did develop

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

A comparison of fibrosis progression in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Noninvasive prediction of fibrosis in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41957.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46675145&oldid=1584886295"